Robert B. Henderson

3.6k citations

42 papers · 2.6k indexed · h-index 21

Impact in

Immunology and Allergy top 1%
- Cell Adhesion Molecules Research
Immunology top 2%
- Immune Response and Inflammation
- T-cell and B-cell Immunology
- Immune Cell Function and Interaction
- Neutrophil, Myeloperoxidase and Oxidative Mechanisms
- Immunotherapy and Immune Responses

Papers in

Immunology and Allergy 9
- Cell Adhesion Molecules Research 9
Hematology 10
- Multiple Myeloma Research and Treatments 6
- Platelet Disorders and Treatments 5

Co-authors: Nancy Hogg Victor L. J. Tybulewicz Kay Fink Meg Mathies R. M. Fink Katia De Filippo Melanie Laschinger Richard E. Cline
Journals: Blood (6 papers)Journal of Biological Chemistry (4 papers)The Journal of Experimental Medicine (2 papers)JCI Insight (2 papers)Nature reviews. Immunology (1 paper)
Partner nations: United Kingdom United States Ireland

In The Last Decade

Robert B. Henderson

42 papers receiving 2.6k citations

Peers

Countries citing papers authored by Robert B. Henderson

Since Specialization

Citations

This map shows the geographic impact of Robert B. Henderson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert B. Henderson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert B. Henderson more than expected).

Fields of papers citing papers by Robert B. Henderson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert B. Henderson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert B. Henderson. The network helps show where Robert B. Henderson may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Robert B. Henderson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Robert B. Henderson Line = papers co-authored together Robert B. Henderson links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Sialofucosylation Enables Platelet Binding to Myeloma Cells via P-Selectin and Suppresses NK Cell-Mediated Cytotoxicity Cancers ·Alessandro Natoni, AmitK Tamrakar, Maria Stefania De Propris, Maria Teresa Petrucci, Francesca Fazio, A. M. Ziegler Michael L. Hulver, Maria Laura Milani, A. Czaplicki, Robert B. Henderson, Dawn Swan, Anna Guarini, Michael O’Dwyer, Robin Foà	2023	6
2	A randomised study of rituximab and belimumab sequential therapy in PR3 ANCA-associated vasculitis (COMBIVAS): design of the study protocol Trials ·Mark McClure, Seerapani Gopaluni, James Wason, Robert B. Henderson, André van Maurik, Abraham Lozada-Rojas, Charles D. Pusey, Alan D. Salama, Paul Lyons, Samuel Gaine Maximilian F. Konig, Kim Mynard, David Jayne, Rachel Jones, (unknown)	2023	11
3	CyBorD-DARA in Newly Diagnosed Transplant-Eligible Multiple Myeloma: Results from the 16-BCNI-001/CTRIAL-IE 16-02 Study Show High Rates of MRD Negativity at End of Treatment Clinical Lymphoma Myeloma & Leukemia ·Dawn Swan, Robert B. Henderson, Inga Wiehl, Schell Kh, John Quinn, Mary R. Cahill, Mavrova Heinrich, Isabelle Arm, Gokhan Cinar, Marc Nolan, Imelda Parker, Alessandro Natoni, Kevin Lynch, Aideen E. Ryan, Éva Szegezdi, Janusz Krawczyk, Philip Murphy, Michael O’Dwyer	2022	1
4	Sonoporation of Human Renal Proximal Tubular Epithelial Cells In Vitro to Enhance the Liberation of Intracellular miRNA Biomarkers Ultrasound in Medicine & Biology ·أ.د. بيداء ستار لفته, Piotr Wojciech Kiebzak, Robert B. Henderson, Bryan R. Conway, Carmel M. Moran, Jeremy Hughes, Laura Denby	2022	6
5	A randomized, phase II study of sequential belimumab and rituximab in primary Sjögren’s syndrome JCI Insight ·Xavier Mariette, Francesca Barone, Chiara Baldini, Hendrika Bootsma, Kenneth L. Clark, Salvatore De Vita, David H. Gardner, Robert B. Henderson, Michael Herdman, Karoline Lerang, Prafull Mistry, Haiyang Xie, Raphaèle Séror, John H. Stone, Paul Van Daele, André van Maurik, Nicolas Wisniacki, David A. Roth, Paul P. Tak	2022	70
6	Identifying cell-enriched miRNAs in kidney injury and repair JCI Insight ·Katie Connor, أ.د. بيداء ستار لفته, Carolynn Cairns, Victoria Banwell, М. В. Ананьева, Julie Rodor, Angie Julieth Moreno Vega, Riinu Pius, Gillian M. Tannahill, Piotr Wojciech Kiebzak, Caroline O.S. Savage, Jeremy Hughes, Ewen M. Harrison, Robert B. Henderson, Lorna Marson, Bryan R. Conway, Stephen J. Wigmore, Laura Denby	2020	19
7	The role of baseline BLyS levels and type 1 interferon-inducible gene signature status in determining belimumab response in systemic lupus erythematosus: a post hoc meta-analysis Arthritis Research & Therapy ·Zhonghua Weng, Robert B. Henderson, Angela R. Jones-Leone, Shaun Flint, Mark Lennon, Roger A. Levy, Beulah Ji, Damon Bass, David A. Roth	2020	28
8	The CD38low natural killer cell line KHYG1 transiently expressing CD16F158V in combination with daratumumab targets multiple myeloma cells with minimal effector NK cell fratricide Cancer Immunology Immunotherapy ·Subhashis Sarkar, Zhiliang Zhang, J.M. Daly, Alessandro Natoni, Heather Fairfield, Robert B. Henderson, Emma Nolan, Dawn Swan, Jinsong Hu, Michaela R. Reagan, Michael O’Dwyer	2020	12
9	Hypersialylation Protects Multiple Myeloma Cells from NK Cell-Mediated Immunosurveillance and This Can be Overcome By Targeted Desialylation Using a Sialyltransferase Inhibitor Blood ·J.M. Daly, Subhashis Sarkar, Alessandro Natoni, Robert B. Henderson, Dawn Swan, Mattias Carlsten, Michael O’Dwyer	2019	7
10	Phase III, multicentre, randomised, double-blind, placebo-controlled, 104-week study of subcutaneous belimumab administered in combination with rituximab in adults with systemic lupus erythematosus (SLE): BLISS-BELIEVE study protocol BMJ Open ·Y K Onno Teng, Ian N Bruce, Betty Diamond, Richard Furie, Ronald van Vollenhoven, David Gordon, James Groark, Robert B. Henderson, Mary Oldham, Paul P. Tak	2019	82
11	Belimumab in kidney transplantation: an experimental medicine, randomised, placebo-controlled phase 2 trial The Lancet ·Gemma D. Banham, Shaun Flint, Nicholas Torpey, Paul Lyons, Zhimimg Zhang, Adele Gibson, Christopher J.E. Watson, Mascha Prengel, Александр Сергеевич Пониматко, Katie Foster, Rachel Jones, Luke Devey, Anna Richards, Lars‐Peter Erwig, Caroline O.S. Savage, Kenneth G. C. Smith, Robert B. Henderson, Menna R. Clatworthy	2018	69
12	A distinct plasmablast and naive B-cell phenotype in primary immune thrombocytopenia Haematologica ·Shaun Flint, Adele Gibson, G. Lucas, Dingguo Zhao, M.B. Lagunova, Drew Provan, Adrian C. Newland, Caroline O. S. Savage, Robert B. Henderson	2016	8
13	PtdIns3P and Rac direct the assembly of the NADPH oxidase on a novel, pre-phagosomal compartment during FcR-mediated phagocytosis in primary mouse neutrophils Blood ·Karen E. Anderson, Tamara Chessa, Keith Davidson, Robert B. Henderson, Simon Walker, Tanya Tolmachova, Katarzyna Grys, Oliver Rausch, Miguel C. Seabra, Victor L. J. Tybulewicz, Len Stephens, Phillip T. Hawkins	2010	51
14	Rho family GTPases and their regulators in lymphocytes Nature reviews. Immunology ·Victor L. J. Tybulewicz, Robert B. Henderson	2009	225
15	Neutrophil Chemokines KC and Macrophage-Inflammatory Protein-2 Are Newly Synthesized by Tissue Macrophages Using Distinct TLR Signaling Pathways The Journal of Immunology ·Katia De Filippo, Robert B. Henderson, Melanie Laschinger, Nancy Hogg	2008	242
16	Activation of the Small GTPase Rac2 via the B Cell Receptor Regulates B Cell Adhesion and Immunological-Synapse Formation Immunity ·Eloísa Arana, Anne Vehlow, Naomi E. Harwood, Elena Vigorito, Robert B. Henderson, Martin Turner, Victor L. J. Tybulewicz, Facundo D. Batista	2008	128
17	Mechanisms contributing to the activity of integrins on leukocytes Immunological Reviews ·Nancy Hogg, Robert B. Henderson, Birgit Leitinger, Alison McDowall, Joanna C. Porter, Paula Stanley	2002	140
18	The Use of Lymphocyte Function–Associated Antigen (Lfa)-1–Deficient Mice to Determine the Role of Lfa-1, Mac-1, and α4 Integrin in the Inflammatory Response of Neutrophils The Journal of Experimental Medicine ·Robert B. Henderson, Lina H. K. Lim, Philippe A. Tessier, Felicity N. E. Gavins, Meg Mathies, Mauro Perretti, Nancy Hogg	2001	152
19	Synthesis of Thymine (Methyl-C¹⁴)¹ Journal of the American Chemical Society ·Robert B. Henderson, R. M. Fink, Kay Fink	1955	5
20	β-AMINOISOBUTYRIC ACID IN RAT URINE FOLLOWING ADMINISTRATION OF PYRIMIDINES Journal of Biological Chemistry ·Kay Fink, Robert B. Henderson, R. M. Fink	1952	69

About Robert B. Henderson

Robert B. Henderson is a scholar working on Immunology and Allergy, Hematology, Immunology, Genetics and Rheumatology, having authored 42 papers that have together received 2.6k indexed citations. Recurring topics across this work include Cell Adhesion Molecules Research (9 papers), T-cell and B-cell Immunology (7 papers), Multiple Myeloma Research and Treatments (6 papers), Platelet Disorders and Treatments (5 papers), Immune Cell Function and Interaction (5 papers), Immune Response and Inflammation (5 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). The work is most often cited by research in Immunology and Allergy (420 citations), Immunology (1.1k citations), Hematology (274 citations), Transplantation (53 citations) and Rheumatology (243 citations). Robert B. Henderson has collaborated with scholars based in United Kingdom, United States and Ireland. Frequent co-authors include Nancy Hogg, Victor L. J. Tybulewicz, Kay Fink, Meg Mathies, R. M. Fink, Katia De Filippo, Melanie Laschinger, Richard E. Cline, Robert M. Fink and Ann P. Wheeler. Their work appears in journals such as Blood, Journal of Biological Chemistry, The Journal of Experimental Medicine, JCI Insight and Nature reviews. Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact